Lipoprotein(a)-to-HDL-C ratio and risk of repeat revascularization and in-stent restenosis after PCI in patients with chronic coronary syndrome undergoing follow-up coronary imaging.
Sep 2026· Biomarkers in Medicine· pp.
1-14
· 0 citations· 32 references
Medicine
TL;DR
It is suggested that LHR may serve as a complementary lipid-related marker for long-term risk stratification in this population of patients with chronic coronary syndrome after percutaneous coronary intervention (PCI).
Abstract
Background
We proposed a novel lipoprotein(a)-to-HDL-C ratio (LHR) and examined its association with repeat revascularization and in-stent restenosis (ISR) in patients with chronic coronary syndrome (CCS) after percutaneous coronary intervention (PCI).
Methods
A total of 2,238 patients with CCS undergoing DES-PCI who had available follow-up coronary imaging were included and categorized into tertiles according to lnLHR values. The primary outcome was a composite of repeat revascularization and ISR. Kaplan-Meier analysis, multivariable Cox regression, restricted cubic spline analysis, and prediction model evaluation were performed.
Results
During a median follow-up of 60 months, 1,031 patients (46.07%) experienced the primary endpoint. Higher lnLHR tertiles were associated with lower event-free survival (p = 0.002). After multivariable adjustment, lnLHR remained independently associated with the primary endpoint (HR, 1.08; 95% CI, 1.02-1.14; p = 0.009), and patients in the highest tertile had a higher risk than those in the lowest tertile (HR, 1.19; 95% CI, 1.02-1.39; p = 0.026). RCS analysis demonstrated a linear association between lnLHR and outcomes. The LHR-based model showed modest discrimination, with AUCs of 0.629 at 3 years and 0.648 at 5 years.
Conclusions
An elevated LHR was independently associated with an increased risk of repeat revascularization and ISR after PCI in CCS patients. These findings suggest that LHR may serve as a complementary lipid-related marker for long-term risk stratification in this population.
Background & Objective In-stent restenosis (ISR) remains a major obstacle after drug-eluting stent (DES) implantation in patients with coronary heart disease (CHD), in which dyslipidemia play important roles. The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) have emerged...
Elevated RC, rather than isolated high LDL-C, is associated with adverse outcomes, which may help identify patients with residual lipid-related risk, which may help identify patients with residual lipid-related risk in STEMI patients after primary PCI.
Qian-Ying Xie, Chao-Yi Wang, Wen-Jing Zhao et al.· Frontiers in Cardiovascular...· 0 citations
Key predictive factors for post-PCI restenosis in CAD patients with DM through case-control analysis were identified and the nomogram model showed good discrimination on internal bootstrap validation, and may provide a useful exploratory tool to support risk stratification and inform management aimed at reducing the re...
Ping Wang, Hong-Yu Peng, Qian Fan et al.· PeerJ· 0 citations
Background Metabolic abnormalities may contribute to in-stent restenosis (ISR) after percutaneous coronary intervention, but the comparative associations of commonly used metabolic indices with ISR within the same patient population remain incompletely characterized. Objective To compare the associations of the triglyc...
Fabrice Yves Ndjana Lessomo, Yin-Hua Luo, Di Fan et al.· Frontiers in Endocrinology· 0 citations
OBJECTIVE
Young patients with myocardial infarction (MI) remain at risk for recurrent cardiovascular events despite favorable short-term outcomes. The prognostic significance of the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol (non-HDL-C/HDL-C) ratio in this population remains insuff...
M. Keten, Kadir Bıyıklı· Türk Kardiyoloji Derneği a...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.